• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Elsevier's 2024 Intravenous Medications

Elsevier's 2024 Intravenous Medications

A Handbook for Nurses and Health Professionals

9780443118838
231,79 zł
197,02 zł Zniżka 34,77 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 197,02 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis

Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elseviers Intravenous Medications:: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2024 edition are 8 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.

Szczegóły produktu
Elsevier
94095
9780443118838
9780443118838

Opis

Rok wydania
2023
Numer wydania
40
Oprawa
miękka bindowana
Liczba stron
1376
Wymiary (mm)
152 x 229
Waga (g)
1610
  • Evolve website information General Dilution Charts How to Use This Book Preface Format and Content of Intravenous Medications Key to Abbreviations Important IV Therapy Facts Resources Preparation and Administration of Injectable Drugs IV Drugs Appendix A: Recommendations for the Safe Use and Handling of Cytotoxic Drugs Appendix B: FDA Pregnancy Categories Appendix C: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) Appendix D: Information for Patients Receiving Immunosuppressive Agents Appendix E: Recently Approved Drugs Index

Komentarze (0)